Anorexia Nervosa: Medical mechanisms, diagnosis, complications, and evidence-based treatment strategies

By | June 27, 2026

Anorexia nervosa is a serious eating disorder characterized by persistent restriction of energy intake leading to significantly low body weight, an intense fear of weight gain, and disturbance in the way body weight or shape is experienced. Clinically, it is not merely “dieting” or a personal preference; it is a psychiatric condition with profound physiologic consequences, including endocrine, cardiovascular, metabolic, and gastrointestinal dysfunction. Understanding its mechanisms requires an integrated biopsychosocial model: genetic vulnerability, neurobiological alterations in reward and threat processing, cognitive-behavioral patterns, and sociocultural pressures can interact to perpetuate restriction.

Neurobiologically, anorexia nervosa involves dysregulation in appetite and satiety signaling and altered function of neural circuits governing cognitive control, anxiety, and reward. Starvation itself can reinforce symptoms: malnutrition and ketosis can increase irritability, cognitive rigidity, and preoccupation with food. Dysregulation of hypothalamic-pituitary-gonadal and hypothalamic-pituitary-thyroid axes commonly results in amenorrhea, hypogonadism, and reduced thyroid hormone conversion, even when thyroid-stimulating hormone may be relatively preserved. Growth hormone secretion may rise, while leptin levels fall due to low fat mass, contributing to impaired reproductive function and altered energy homeostasis.

From a cardiovascular standpoint, restriction can produce bradycardia, hypotension, and reduced cardiac output. Electrolyte abnormalities such as hypokalemia, hypomagnesemia, and sometimes hypophosphatemia can impair cardiac conduction and increase arrhythmia risk. QT prolongation may occur, particularly when electrolyte disturbances coexist or when medications contribute. Bone health is similarly affected: chronic low estrogen and altered bone remodeling lead to osteopenia and osteoporosis, increasing fracture risk.

Gastrointestinal complications are frequent. Reduced motility can cause constipation, bloating, and abdominal pain; gastroparesis may occur in severe cases. Patients may also develop micronutrient deficiencies, including iron, zinc, folate, and vitamin D, amplifying fatigue, immune dysfunction, hair loss, and impaired tissue repair. Hematologic abnormalities can include anemia or leukopenia, reflecting malnutrition and marrow suppression.

Psychologically, anorexia nervosa is sustained by cognitive distortions about body size, shape, and personal control. Common features include perfectionism, harm-avoidance, and high sensitivity to criticism; these patterns can be maintained by rituals around food, rigid rules regarding “safe” foods, and avoidance of situations that trigger perceived weight-related threat. The fear of gaining weight can become overvalued, leading to persistent restriction even as physical consequences escalate. Insight varies, and some individuals may also meet criteria for comorbid anxiety disorders, obsessive-compulsive symptoms, depression, or post-traumatic stress.

Diagnosis relies on clinical criteria. A medical evaluation is essential to determine severity and exclude other causes of weight loss, such as inflammatory bowel disease, malignancy, hyperthyroidism, diabetes with insulin deficiency, substance use, or medication effects. Baseline assessment typically includes vital signs, orthostatic measurements, blood tests (electrolytes, renal and liver function, complete blood count, thyroid function, magnesium, phosphate), and an ECG. Weight history, growth curves, and menstrual history support longitudinal severity assessment.

Treatment is evidence-based and must address both medical stabilization and psychiatric recovery. In acute, high-risk presentations—such as bradycardia, syncope, significant electrolyte derangements, or rapid decline—hospitalization may be required for monitoring and cautious nutritional rehabilitation. Refeeding must be conducted carefully to prevent refeeding syndrome, a potentially fatal shift in fluids and electrolytes driven by renewed carbohydrate intake, typically precipitating hypophosphatemia and thiamine deficiency. Clinical protocols often include gradual reintroduction of calories, electrolyte surveillance, thiamine supplementation, and controlled symptom monitoring.

Psychotherapeutic care is central. For adolescents, Family-Based Treatment (FBT) is a first-line model: it empowers caregivers to support structured, weight-restoring nutrition while reducing eating-disorder behaviors. For adults and for certain clinical situations, Cognitive Behavioral Therapy for Eating Disorders (CBT-E) and other structured approaches target maintaining mechanisms such as restriction cycles, body checking, and weight/shape overvaluation. When severe depression, suicidality, or comorbid anxiety is present, integrated care with psychiatric management is appropriate; pharmacotherapy may help specific symptom domains, though there is no single medication that “cures” anorexia nervosa. Selective serotonin reuptake inhibitors have mixed evidence for core eating-disorder symptoms, and medications must be selected cautiously given cardiac and metabolic risk.

Recovery is often non-linear. Prognosis depends on early intervention, restoration of weight and nutrition, and sustained engagement in therapy. Relapse prevention focuses on flexible coping skills, reducing compulsive compensatory behaviors, managing triggers, and building a sustainable relationship with food and body-related thoughts.

If you or someone you know is experiencing severe restriction, fainting, chest pain, extreme fatigue, or rapid weight loss, urgent medical evaluation is critical. Source: @whisperwaif

News Source

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

Leave a Reply

Your email address will not be published. Required fields are marked *